Intravenous Paracetamol Versus Ketoprofen When Treating Renal Colic in Emergency Situations
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE NĪMES · Sep 12, 2012
Trial Information
Current as of June 07, 2025
Withdrawn
Keywords
ClinConnect Summary
The secondary objectives of this study are:
* To compare the efficacy (non-inferiority) of intravenous paracetamol and ketoprofen at 90 minutes (vns for pain).
* To compare both arms in terms of other administered drugs (for pain).
* To observe and compare side effects between the two arms: cutaneous manifestation, edema, bronchospasm, nausea, vomiting, headache, palpitation, chest pain, dizziness, disturbance of consciousness, dyspnea, acute retention of urine.
* To determine predictors for the use of intravenous morphine when treating renal colic.
* To compare hospitalization rates betwe...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient must have given his/her informed and signed consent
- • The patient must be insured or beneficiary of a health insurance plan
- • The patient is available for a telephone interview at week 1
- • Patient consulting at the Nîmes University Hospital emergency ward with suspicion of renal colic
- Exclusion Criteria:
- • The patient is participating in another study
- • The patient is in an exclusion period determined by a previous study
- • The patient is under judicial protection, under tutorship or curatorship
- • The patient refuses to sign the consent
- • It is impossible to correctly inform the patient
- • The patient is pregnant, parturient, or breastfeeding
- • The patient has a contraindication for a treatment used in this study
- • The patient has an allergy to ketoprofen or paracetamol, a history of gastric or intestinal ulcers, bleeding disorders, history of asthma triggered by taking ketoprofen or substances with similar activity such as other NSAIDs or aspirin
- • The patient has a fever or is hemodynamically unstable, oligoanuria
- • The patient presents with an initial verbal numeric pain score of 10/10.
- • The patient has a history of aneurysm or aortic dissection, history of renal transplantation, history of renal or hepatic insufficiency
- • The patient took paracetamol or ketoprofen 4 hours before emergency treatment.
About Centre Hospitalier Universitaire De Nīmes
The Centre Hospitalier Universitaire de Nîmes (CHU Nîmes) is a leading academic medical center located in Nîmes, France, dedicated to advancing healthcare through innovative clinical research and patient care. As a prominent sponsor of clinical trials, CHU Nîmes collaborates with a multidisciplinary team of healthcare professionals and researchers to conduct rigorous studies aimed at improving treatment outcomes and enhancing medical knowledge across various specialties. With a strong commitment to ethical standards and patient safety, CHU Nîmes fosters a research environment that encourages scientific excellence and contributes to the development of new therapies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alès, , France
Nîmes Cedex 9, , France
Patients applied
Trial Officials
Pierre-Géraud Claret, MD
Principal Investigator
Centre Hospitalier Universitaire de Nîmes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials